Literature DB >> 6487460

Pinacidil monotherapy for hypertension.

J W Ward.   

Abstract

Ten patients with mild to moderate hypertension were treated for 9 weeks with a tablet formulation of pinacidil. Mean supine blood pressure fell from 174/100 to 148/84 mm Hg and mean supine pulse increased by 3 beats/min. Daily dosage was 40-100 mg, given in two or three divided doses. Plasma urea increased significantly and mean weight increased by 1.1 kg. Side effects were frequent but mild, in the main being those typically associated with potent vasodilator drugs. No patient withdrew from the study, and all achieved target blood pressure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487460      PMCID: PMC1463528          DOI: 10.1111/j.1365-2125.1984.tb02456.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.

Authors:  J E Carlsen; T Kardel; T Hilden; M Tangø; J Trap-Jensen
Journal:  Clin Physiol       Date:  1981-08

2.  Pharmacokinetics and distribution of the new antihypertensive agent pinacidil in rat, dog and man.

Authors:  E Eilertsen; J W Hart; M P Magnussen; H Sørensen; E Arrigoni-Martelli
Journal:  Xenobiotica       Date:  1982-03       Impact factor: 1.908

3.  Preliminary evaluation of pinacidil in hypertension.

Authors:  L E Ramsay; S Freestone
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

4.  Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.

Authors:  J E Carlsen; T Kardel; H A Jensen; M Tangø; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  4 in total
  9 in total

Review 1.  Pinacidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.

Authors:  H A Friedel; R N Brogden
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

2.  Pinacidil activates the ATP-sensitive K+ channel in inside-out and cell-attached patch membranes of guinea-pig ventricular myocytes.

Authors:  Z Fan; K Nakayama; M Hiraoka
Journal:  Pflugers Arch       Date:  1990-01       Impact factor: 3.657

3.  Pharmacodynamic model of the haemodynamic effects of pinacidil in normotensive volunteers.

Authors:  P Girard; J L Saumet; F Dubois; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  The effects of long-acting pinacidil on intra-arterial blood pressure.

Authors:  M P Caruana; I Al-Khawaja; P Royston; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

5.  Effects of pinacidil on the sympatho-adrenal system in dogs.

Authors:  C Damase-Michel; M A Tran; J L Montastruc; J P Moatti; P Montastruc
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

6.  Hypotensive and peripheral vascular effects in healthy volunteers of repeated oral administration of pinacidil.

Authors:  J L Saumet; F Dubois; P Girard; A Geloen; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Acute haemodynamic effects of pinacidil in man.

Authors:  D P Nicholls; J G Murtagh; M E Scott; P Morton; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

8.  Accumulation of pinacidil N-oxide during chronic treatment with pinacidil.

Authors:  A McBurney; J A Henry; J W Ward
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Renal effects of pinacidil in hypertensive patients on chronic beta-blocker therapy.

Authors:  L R Krusell; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.